Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants
✍ Scribed by Chuan-Zhong Yang; Jiun Lee
- Book ID
- 107659758
- Publisher
- SP Children’s Hospital, Zhejiang University School of Medicine
- Year
- 2008
- Tongue
- English
- Weight
- 133 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1708-8569
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Indomethacin has proven effective in closing the patent ductus arteriosus (PDA) in most low birth weight (LBW) neonates with this disorder. Early reopening of the ductus is a problem and often leads to the need for surgery. Prolonged use of indomethacin for several days has been suggested as a means
First results are described of individually tailored indomethacin dose rates employing on-line drug level monitoring for pharmacologically induced ductal constriction in very low birth weight infants with symptomatic patent ductus arteriosus (sPDA). In addition prolonged indomethacin therapy was int